Virginia Tech Scientists Lead Study on Tobacco Tax Impact

Nov.22.2022
Virginia Tech Scientists Lead Study on Tobacco Tax Impact
A $3.5 million, five-year study at Virginia Tech predicts tobacco tax effects on public health through a complex experimental market.

Scientists at the Fralin Biomedical Research Institute at Virginia Tech are leading a five-year, $3.5 million research project to predict the impact of tobacco taxes on health.


Taxation is one of the most effective ways to change behavior - it makes people think about their choices, including their choice to use tobacco," said Warren Bickel, professor at the Fralin Biomedical Research Institute and director of the Addictions Recovery Center at the institute.


Bickel's research project, funded by the National Cancer Institute of the National Institutes of Health in the United States, aims to predict the impact of tobacco tax proposals in a complex experimental market. This market is constantly evolving with the introduction of new products, such as low-nicotine cigarettes or electronic cigarettes.


According to Virginia Tech, this project could potentially provide research-based health policy guidance for new tobacco regulations and assess the impact of people's economic choices on health.


Taxation is one of the most effective ways to change behavior - it makes people consider their choices, including their choice to use tobacco.


Warren Bickel, Director of the Addictions Recovery Research Center at the Fralin Biomedical Research Institute.


Taxes can help people achieve better health by discouraging them from smoking. If you make the product more expensive, people will be less likely to use it. They can also encourage people to switch from the most harmful tobacco products to the least harmful ones," said Bickel, who is also the director of the research institute's Health Behavior Research Center.


He will consider health disparities related to tobacco by investigating socio-economic factors.


Smoking rates are higher among low-income populations, and disproportionate tax policies may have far-reaching direct and unforeseen effects," said Professor Becker of the Virginia Tech College of Science.


To gain definitive answers, Bickel's approach involves conducting experiments in the tobacco market, which is an invention of the Center for Addictions Recovery Research. Participants have an account and purchase tobacco products to reflect their typical buying behavior. Joint researchers involved in the project include Jeff Stein and Allison Tegge from the Fralin Biomedical Research Institute and Bickel.


The market places a combination of products, prices, and specific regulations under experimental control to enable researchers to estimate the impact of policies in a realistic environment.


In this context, researchers can predict the impact and health equity of proposed tax policies, including a proposal for equal taxation of all tobacco products, as well as other proposals based on the product's nicotine content, potential harm, or whether the tobacco product is already taxed. The FDA's revised risk designation.


We can implement policies in the experimental tobacco market and provide information on the effects of tobacco purchases on people," said Bickel. "For example, if legislators or regulators restrict access to one product over another, will it lead smokers to make less healthy or healthier choices? It is an ideal resource for studying the harm reduction potential of low-nicotine cigarettes and alternative nicotine products.


Statement:


This article has been compiled from third-party information and is intended for industry professionals for discussion and educational purposes.


This article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the authenticity and accuracy of the article. The compilation of this article is only intended for industry communication and research purposes.


As the translation is limited by the compiler's ability, the translated article may not fully convey the original meaning. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government on any domestic, Hong Kong, Macau, Taiwan, or foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for removal.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia House passes “Vape Safety Act of 2026,” creating licensing and product directory requirements
West Virginia’s House of Delegates passed the Vape Safety Act of 2026, a proposal to tighten oversight of vape and smoke shops through licensing, fees and enforcement. The bill would establish a state directory requiring vape products sold in West Virginia to have FDA marketing authorization or a pending application under FDA review to be listed, and only directory-listed products could be sold starting Sept. 1, 2026 if enacted.
Feb.28 by 2FIRSTS.ai
Philippine Customs Seizes Illegal Vape Products Worth Up to PHP 1.4 Billion in Navotas Warehouse
Philippine Customs Seizes Illegal Vape Products Worth Up to PHP 1.4 Billion in Navotas Warehouse
The Philippine Bureau of Customs seized illegal vape products worth an estimated PHP 1 billion to PHP 1.4 billion at a warehouse in Navotas City. Customs Commissioner Ariel Nepomuceno said the operation was the agency’s largest crackdown on illegal vape products since 2024.
Mar.23 by 2FIRSTS.ai
Product | Lost Vape launches “4D portable shisha” device with 3,800mAh battery and up to 80W output
Product | Lost Vape launches “4D portable shisha” device with 3,800mAh battery and up to 80W output
E-cigarette brand Lost Vape has recently listed its open-system DTL device, the ASTARA, on its official website. The company markets the product as “The First 4D Portable Shisha Experience,” highlighting a 360-degree display and audio features. The ASTARA has also appeared on some online sales channels in markets including the UK and Germany.
Feb.03 by 2FIRSTS.ai
UKVIA Says VApril 2026 Will Highlight Consumer Impact of Tobacco and Vapes Bill
UKVIA Says VApril 2026 Will Highlight Consumer Impact of Tobacco and Vapes Bill
The UK Vaping Industry Association said it will launch the ninth annual VApril campaign next month. The association described VApril as the world’s largest vape awareness initiative and said it has for almost a decade supported adult smokers looking to quit through vaping by providing evidence-based information, expert insights and practical guidance
Mar.24 by 2FIRSTS.ai
Deputy Mikhail Ivanov delivers a lesson on the harms of vapes to Sormovo school students
Deputy Mikhail Ivanov delivers a lesson on the harms of vapes to Sormovo school students
According to the United Russia Nizhny Novgorod branch website, Nizhny Novgorod City Duma deputy chair Mikhail Ivanov (Mikhail Ivanov) spoke to students at School No. 78 about the harms of vapes, electronic nicotine delivery systems and nicotine-free liquids, stressing that such topics should be discussed with children “honestly” and “only with facts.”
Feb.28 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24